These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 38934120
1. GRHPR, Targeted by miR-138-5p, Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma Through PI3K/AKT Signaling Pathway. Yang S, Liu Y, Zhang B, Li J, Xu F, Yu M, Chen Y, Li C, Liu T, Zhao Y, Zhao Q, Zhang J. Cancer Biother Radiopharm; 2024 Dec; 39(10):733-744. PubMed ID: 38934120 [Abstract] [Full Text] [Related]
2. Long Non-coding RNA 02298 Promotes the Malignancy of HCC by Targeting the miR-28-5p/CCDC6 Pathway. Wang J, Xu B, Liang L, Chen Q. Biochem Genet; 2024 Dec; 62(6):4967-4986. PubMed ID: 38381357 [Abstract] [Full Text] [Related]
3. EGCG targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization mediated by gastric cancer cell-derived exosomal miR-92b-5p. Yi J, Ye Z, Xu H, Zhang H, Cao H, Li X, Wang T, Dong C, Du Y, Dong S, Zhou W. Phytomedicine; 2024 Dec; 135():156137. PubMed ID: 39566403 [Abstract] [Full Text] [Related]
4. The miR-1269a/PCDHGA9/CXCR4/β-catenin pathway promotes colorectal cancer invasion and metastasis. Mei H, Luo Q, Weng J, Hao J, Cai J, Zhou R, Bian C, Ye Y, Luo S, Wen Y. Cell Mol Biol Lett; 2024 Nov 26; 29(1):144. PubMed ID: 39587482 [Abstract] [Full Text] [Related]
5. [GINS1 Enhances Glycolysis, Proliferation and Metastasis in Lung Adenocarcinoma Cells by Activating the Notch/PI3K/AKT/mTORC1 Signaling Pathway]. Huo Y, Xu X, Ma X, Feng Y. Zhongguo Fei Ai Za Zhi; 2024 Oct 20; 27(10):735-744. PubMed ID: 39631830 [Abstract] [Full Text] [Related]
6. Britannin inhibits hepatocellular carcinoma development and metastasis through the GSK-3β/β-catenin signaling pathway. Lu Q, Zhu J, Teng L, Chen C, Bi L, Chen W. Phytomedicine; 2024 Dec 20; 135():156126. PubMed ID: 39427522 [Abstract] [Full Text] [Related]
7. CircLPHN3 correlates with prognosis in colorectal cancer and regulates cellular processes by targeting miR-142-5p. Zhang J, Cai Y. Int J Biol Markers; 2024 Dec 20; 39(4):292-300. PubMed ID: 39420826 [Abstract] [Full Text] [Related]
8. circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression. Liu G, Guo W, Rao M, Qin J, Hu F, Li K. Cell Transplant; 2020 Dec 20; 29():963689720963948. PubMed ID: 33028110 [Abstract] [Full Text] [Related]
9. BVES-AS1 suppresses the colorectal cancer progression via the miR-1269a/b-SVEP1-PI3K/AKT axis. Yang J, Deng Q, Chen Z, Chen Y, Fu Z. Adv Clin Exp Med; 2024 Nov 20; 33(11):1217-1236. PubMed ID: 38239081 [Abstract] [Full Text] [Related]
10. Upregulation of LncRNA WT1-AS Inhibits Tumor Growth and Promotes Autophagy in Gastric Cancer via Suppression of PI3K/Akt/mTOR Pathway. Zhang X, Jin M, Yao X, Liu J, Yang Y, Huang J, Jin G, Liu S, Zhang B. Curr Mol Pharmacol; 2024 Nov 20; 17():e18761429318398. PubMed ID: 39592900 [Abstract] [Full Text] [Related]
11. miR-122/NEGR1 axis contributes colorectal cancer liver metastasis by PI3K/AKT pathway and macrophage modulation. Dai S, Zhuang H, Li Z, Chen Z, Chai Y, Zhou Q. J Transl Med; 2024 Nov 25; 22(1):1060. PubMed ID: 39587606 [Abstract] [Full Text] [Related]
12. Decreased lncRNA HNF4A-AS1 facilitates resistance to sorafenib-induced ferroptosis of hepatocellular carcinoma by reprogramming lipid metabolism. Zhao Y, Han S, Zeng Z, Zheng H, Li Y, Wang F, Huang Y, Zhao Y, Zhuo W, Lv G, Wang H, Zhao G, Zhao E, Hu Y, Hu P, Zhao G. Theranostics; 2024 Nov 25; 14(18):7088-7110. PubMed ID: 39629121 [Abstract] [Full Text] [Related]
14. Hypocrellin A against intrahepatic Cholangiocarcinoma via multi-target inhibition of the PI3K-AKT-mTOR, MAPK, and STAT3 signaling pathways. Chen B, Chen Q, Lu M, Zou E, Lin G, Yao J, Wang L, Gan Y, Chen B, Chen G, Wu L. Phytomedicine; 2024 Dec 25; 135():156022. PubMed ID: 39284270 [Abstract] [Full Text] [Related]
15. Casticin suppresses self-renewal related stemness via miR-342-3p-mediated FoxM1 downregulation in cervical cancer cells. Cao X, Hu X, Xu X, Zhu W, Lin Q, Le Y, Feng W, Xu Y, Lin S. Phytomedicine; 2024 Dec 25; 135():156036. PubMed ID: 39277988 [Abstract] [Full Text] [Related]
17. MiR-15a-5p Knockdown up-Regulated ABCB1 Expression and Abated HNSCC Progression via the NF-κB Signaling Pathway. Liu J, Lv C, Aghayants S, Wang Y. J Invest Surg; 2024 Dec 25; 37(1):2434096. PubMed ID: 39608783 [Abstract] [Full Text] [Related]
18. Targeting autophagy in HCC treatment: exploiting the CD147 internalization pathway. Qian M, Wan Z, Liang X, Jing L, Zhang H, Qin H, Duan W, Chen R, Zhang T, He Q, Lu M, Jiang J. Cell Commun Signal; 2024 Dec 03; 22(1):583. PubMed ID: 39627812 [Abstract] [Full Text] [Related]
19. A N7-methylguanosine modified circular RNA, circIPP2A2, promotes malignant behaviors in hepatocellular carcinoma by serving as a scaffold in modulating the Hornerin/PI3K/AKT/GSK3β axis. Guo Z, Li Z, Guo J, Gan L, Mo H, Zhang J, Fu Y, Wang Y, Jin M, Wu Y, Xie Q, Tan K, Wang C, Xu Y, He G, Cai L, Gao Y, Pan M, Fu S. Cell Death Dis; 2024 Nov 30; 15(11):868. PubMed ID: 39616161 [Abstract] [Full Text] [Related]
20. Transcription factor ASCL1 targets SLC6A13 to inhibit the progression of hepatocellular carcinoma via the glycine-inflammasome signaling. Zhang H, Zong R, Wu H, Jiang J, Liu C, Liu S. Biomol Biomed; 2024 Oct 17; 24(6):1606-1619. PubMed ID: 38780447 [Abstract] [Full Text] [Related] Page: [Next] [New Search]